The risk of cutaneous mucormycosis associated with COVID-19: A perspective from Pakistan.
Int J Health Plann Manage
; 37(2): 1157-1159, 2022 Mar.
Article
in English
| MEDLINE | ID: covidwho-1384176
ABSTRACT
As a developing country, Pakistan reports a high burden of fungal diseases, of which cutaneous mucormycosis remains a prominent infection, presenting as a highly invasive disease with significant mortality. Apart from a high population of at-risk individuals, multiple factors have precipitated an increment in mucormycosis cases in the country following the COVID-19 pandemic. These include increased use of corticosteroids, immunosuppression following the viral infection, prolonged stays in the intensive care unit and sub-optimal laboratory testing available in the country. This article aims to assess the potential implications of a mucormycosis epidemic on a healthcare system already strained under the COVID-19 pandemic, and provides subsequent recommendations to weather the dual challenge of two deadly pathogens.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Mucormycosis
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Int J Health Plann Manage
Journal subject:
Health Services Research
/
Health Services
Year:
2022
Document Type:
Article
Affiliation country:
Hpm.3311
Similar
MEDLINE
...
LILACS
LIS